Skip to content

Why Subscribe
About Us
Accreditation
Library
Live Events
Sign Up / Login

Why Subscribe
About Us
Accreditation
Library
Live Events
Sign Up / Login

Library

By pinki shah / May 14, 2022

Speciality

Author / Speaker

Title of Presentation

Type of Media

Event

2024 Event

Clear

Displaying 2,051 - 2,075 of 2,711

«
1
…
81
82
83
84
85
…
109
»

Diffuse Large B-Cell Lymphoma: Updates and Future Directions

Diffuse Large B-Cell Lymphoma: Updates and Future Directions

By: Luis E. Fayad, MD

Update from ASCO/AACR/ESMO in T-cell NHL

Update from ASCO/AACR/ESMO in T-cell NHL

By: Luis E. Fayad, MD

Update from ASCO/AACR/ESMO in T-cell NHL

Update from ASCO/AACR/ESMO in T-cell NHL

By: Luis E. Fayad, MD

Novel Advances in T-Cell NHL Therapies

Novel Advances in T-Cell NHL Therapies

By: Luis E. Fayad, MD

Novel Advances in T-Cell NHL Therapies

Novel Advances in T-Cell NHL Therapies

By: Luis E. Fayad, MD

Lymphoma and CLL Update

Lymphoma and CLL Update

By: Mazyar Shadman, MD, MPH

Lymphoma and CLL Update

Lymphoma and CLL Update

By: Mazyar Shadman, MD, MPH

State of the Art in Early Hodgkin Lymphoma

State of the Art in Early Hodgkin Lymphoma

By: Megan E. Daly, MD

CAR-T Cells and Other Cell Based Therapies

CAR-T Cells and Other Cell Based Therapies

By: Mehrdad Abedi - MD

CAR-T Cells and Other Cell Based Therapies

CAR-T Cells and Other Cell Based Therapies

By: Mehrdad Abedi, MD

Non Hodgkin & Hodgkin Lymphomas

Non Hodgkin & Hodgkin Lymphomas

By: Mohamed A. Kharfan-Dabaja, MD, MBA, FACP

CAR T Cell Therapies in Lymphoid Malignancies: Here to Stay!

CAR T Cell Therapies in Lymphoid Malignancies: Here to Stay!

By: Mohamed A. Kharfan-Dabaja, MD, MBA, FACP

CAR T Cell Therapies in Lymphoid Malignancies: Here to Stay!

CAR T Cell Therapies in Lymphoid Malignancies: Here to Stay!

By: Mohamed A. Kharfan-Dabaja, MD, MBA, FACP

Redefining Treatment Algorithms in B-cell Lymphomas: A Focus on CAR-T Cell TherapyLymphoma

Redefining Treatment Algorithms in B-cell Lymphomas: A Focus on CAR-T Cell TherapyLymphoma

By: Mohamed A. Kharfan-Dabaja, MD, MBA, FACP

Redefining Treatment Algorithms in B-cell Lymphomas: A Focus on CAR-T Cell TherapyLymphoma

Redefining Treatment Algorithms in B-cell Lymphomas: A Focus on CAR-T Cell TherapyLymphoma

By: Mohamed A. Kharfan-Dabaja, MD, MBA, FACP

CAR-T Cell Therapy in Lymphomas: 7-Years Later

CAR-T Cell Therapy in Lymphomas: 7-Years Later

By: Mohamed A. Kharfan-Dabaja, MD, MBA, FACP

CAR-T Cell Therapy in Lymphomas: 7-Years Later

CAR-T Cell Therapy in Lymphomas: 7-Years Later

By: Mohamed A. Kharfan-Dabaja, MD, MBA, FACP

Follicular Lymphoma: Novel Advances and Pathways

Follicular Lymphoma: Novel Advances and Pathways

By: Nahkle Saba, MD

Follicular Lymphoma: Novel Advances and Pathways

Follicular Lymphoma: Novel Advances and Pathways

By: Nahkle Saba, MD

Follicular Lymphoma: When to Start Therapy and How To Decide The Optimal Treatment?

Follicular Lymphoma: When to Start Therapy and How To Decide The Optimal Treatment?

By: Nakhle S. Saba, MD

New Approaches for Follicular Lymphoma

New Approaches for Follicular Lymphoma

By: Nakhle S. Saba, MD

New Approaches for Follicular Lymphoma

New Approaches for Follicular Lymphoma

By: Nakhle S. Saba, MD

Follicular Lymphoma: Defining Best 1L and 2L Treatment in the Era of Personalized Medicine

Follicular Lymphoma: Defining Best 1L and 2L Treatment in the Era of Personalized Medicine

By: Nakhle Saba, MD

Follicular Lymphoma and CLL Updates 2023

Follicular Lymphoma and CLL Updates 2023

By: Nakhle Saba, MD

Follicular Lymphoma: Defining Best 1L and 2L Treatment in the Era of Personalized Medicine

Follicular Lymphoma: Defining Best 1L and 2L Treatment in the Era of Personalized Medicine

By: Nakhle Saba, MD

«
1
…
81
82
83
84
85
…
109
»

Post navigation

← Previous View

© 2024 MEC Inc. All rights reserved | Digital Marketing by Katapult Marketing

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok